1. Chen, Wen, Liu, Zhiwen, Mai, Wenli, You, Xiaolong, Qin, Lei. . FZD8 Indicates a Poor Prognosis and Promotes Gastric Cancer Invasion and Metastasis via B-Catenin Signaling Pathway. In Annals of clinical and laboratory science, 50, 13-23. doi:. https://pubmed.ncbi.nlm.nih.gov/32161008/
2. Li, Qiji, Ye, Liping, Zhang, Xin, Song, Libing, Peng, Xinsheng. 2017. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling. In Cancer letters, 402, 166-176. doi:10.1016/j.canlet.2017.05.029. https://pubmed.ncbi.nlm.nih.gov/28602974/
3. Wang, Yeyang, Zheng, Xiaoyu, Luo, Dixin, Xu, Wangyang, Zhou, Xiaozhong. 2022. MiR-99a alleviates apoptosis and extracellular matrix degradation in experimentally induced spine osteoarthritis by targeting FZD8. In BMC musculoskeletal disorders, 23, 872. doi:10.1186/s12891-022-05822-8. https://pubmed.ncbi.nlm.nih.gov/36127685/
4. Al-Zahrani, Maryam H, Assidi, Mourad, Pushparaj, Peter Natesan, Buhmeida, Abdelbaset, Abu-Elmagd, Muhammad. 2023. Expression pattern, prognostic value and potential microRNA silencing of FZD8 in breast cancer. In Oncology letters, 26, 477. doi:10.3892/ol.2023.14065. https://pubmed.ncbi.nlm.nih.gov/37809047/
5. Shen, Hui, Tian, Yi, Yao, Xiaolei, Zhang, Yujin, Yang, Zhibo. . MiR-99a inhibits keratinocyte proliferation by targeting Frizzled-5 (FZD5) / FZD8 through β-catenin signaling in psoriasis. In Die Pharmazie, 72, 461-467. doi:10.1691/ph.2017.7018. https://pubmed.ncbi.nlm.nih.gov/29441905/